search

Find a Clinical TrialHerbert Irving Comprehensive
Cancer CenterDepartment of MedicineNewYork-Presbyterian Columbia University Medical Center Columbia University

A national newsletter and web site from NYP Hospital.

A publication of the Cancer Centers of NYP Hospital.

Alfred Neugut, M.D. Ph.D.

NEW PATIENTS TEL (212) 305-5098

ADMINISTRATIVE OFFICE TEL (212) 305-9414
FAX (212) 305-9413

OUTPATIENT OFFICE LOCATION

Irving Pavilion 10

161 Fort Washington Ave at W 165th St..

PHYSICIAN SUMMARY

Alfred I. Neugut, M.D., Ph.D., is Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Head of Prevention, Control, and Disparities Research for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital. He is a medical oncologist with a particular interest in GI tract cancers, especially of colorectal and gasteric cancers.

Under the auspices of Columbia's M.D.-Ph.D. program, he received his medical degree and a Ph.D. in Pathobiology in 1977. Further clinical training in Internal Medicine and Medical Oncology was at the Albert Einstein College of Medicine and Memorial Sloan-Kettering Cancer Center, returning to Columbia as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an M.P.H. in Epidemiology in 1983, at which time he joined the faculty with a joint appointment in Medicine and Epidemiology.

Dr. Neugut's research has centered on cancer epidemiology and prevention. He initiated a series of important studies focused on risk factors for the occurrence and recurrence of colorectal adenomatous polyps (adenomas). Along with a variety of students, postdocs, and colleagues, these studies have extended into the use and yield of colonoscopy and fecal occult blood testing for routine screening and diagnosis. An editorial by Dr. Neugut in 1988 was the first to suggest the use of colonoscopy for routine screening of asymptomatic adults, a common practice now.

Dr. Neugut's second major research focus has been the occurrence of second malignancies, especially the impact of radiation therapy. For example, he has found elevated risks of lung cancer and esophageal cancer following breast cancer radiotherapy and of bladder cancer following prostate cancer radiotherapy. Other areas of cancer epidemiology to which he has contributed include cancers of the small bowel, gallbladder, and biliary tree. In addition, he serves currently as Co-Principal Investigator of the Long Island Breast Cancer Study Project.

At the present time, a significant amount of Dr. Neugut's research is centered on studying the use of chemotherapy and radiotherapy for cancer in the elderly. Racial/ethnic variations in quality of cancer care and outcomes are also current research interests as are adherence to treatment and long-term sequelae of cancer therapies. .Dr. Neugut has served as Principal Investigator for the past 15 years of an NCI-funded Training Program in Cancer Epidemiology, Biostatistics, and Environmental Health Sciences. He is the former President of the American Society of Preventive Oncology, probably the leading U.S. organization for research ion cancer epidemiology and prevention. He has served on numerous study sections and review committees, both at NIH and elsewhere.